Plus Therapeutics Inc (PSTV):企業の財務・戦略的SWOT分析

◆英語タイトル:Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0316
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Plus Therapeutics Inc (PSTV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Plus Therapeutics Inc (Plus Therapeutics) is a developmental stage pharmaceutical company which focuses on discovery, development, and manufacturing of complex and innovative treatments for patients with cancer and other life-threatening diseases. Its pipeline products include Doceplus, a patented albumin-stabilized Pegylated liposomal formulation of docetaxel and Doxoplus, a complex, injectable, generic Pegylated liposomal formulation of doxorubicin. The company uses its proprietary nanotechnology platform to reformulate and improve conventional chemotherapeutics to provide meaningful benefits to healthcare providers and patients. Plus is headquartered in Irvine, Texas the US.

Plus Therapeutics Inc Key Recent Developments

Nov 14,2019: Plus Therapeutics reports third quarter 2019 financial and business results
Jul 16,2019: Cytori will become Plus Therapeutics
May 14,2019: Cytori reports Q1 2019 business and financial results
Apr 01,2019: Cytori reports fourth quarter and full year 2018 business and financial results
Nov 14,2018: Cytori reports Q3 2018 business and financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Plus Therapeutics Inc – Key Facts
Plus Therapeutics Inc – Key Employees
Plus Therapeutics Inc – Key Employee Biographies
Plus Therapeutics Inc – Major Products and Services
Plus Therapeutics Inc – History
Plus Therapeutics Inc – Company Statement
Plus Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Plus Therapeutics Inc – Business Description
R&D Overview
Plus Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Plus Therapeutics Inc – Strengths
Plus Therapeutics Inc – Weaknesses
Plus Therapeutics Inc – Opportunities
Plus Therapeutics Inc – Threats
Plus Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Plus Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 14, 2019: Plus Therapeutics reports third quarter 2019 financial and business results
Jul 16, 2019: Cytori will become Plus Therapeutics
May 14, 2019: Cytori reports Q1 2019 business and financial results
Apr 01, 2019: Cytori reports fourth quarter and full year 2018 business and financial results
Nov 14, 2018: Cytori reports Q3 2018 business and financial results
Aug 14, 2018: Cytori reports Q2 2018 business and financial results
Aug 09, 2018: Cytori reports publication of interim pilot data for cell therapy in vocal fold scarring
May 10, 2018: Cytori Reports Q1 2018 Business and Financial Results
Mar 08, 2018: Cytori Reports Fourth Quarter and Full Year 2017 Business and Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Plus Therapeutics Inc, Key Facts
Plus Therapeutics Inc, Key Employees
Plus Therapeutics Inc, Key Employee Biographies
Plus Therapeutics Inc, Major Products and Services
Plus Therapeutics Inc, History
Plus Therapeutics Inc, Other Locations
Plus Therapeutics Inc, Subsidiaries
Plus Therapeutics Inc, Key Competitors
Plus Therapeutics Inc, Ratios based on current share price
Plus Therapeutics Inc, Annual Ratios
Plus Therapeutics Inc, Annual Ratios (Cont...1)
Plus Therapeutics Inc, Interim Ratios
Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Plus Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Plus Therapeutics Inc, Performance Chart (2014 - 2018)
Plus Therapeutics Inc, Ratio Charts
Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Plus Therapeutics Inc (PSTV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hon Hai Precision Industry Co., Ltd.:企業のM&A・事業提携・投資動向
    Hon Hai Precision Industry Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hon Hai Precision Industry Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Gentag Inc-医療機器分野:企業M&A・提携分析
    Summary Gentag Inc (Gentag) is a medical device company that patent and develops wireless sensor technology products. The company provides wireless products to personal health and diagnostics. It offers wireless sensor network services. Gentag’s products comprise medication and packaging sensor, imm …
  • Chinook Energy Inc (CKE):石油・ガス:M&Aディール及び事業提携情報
    Summary Chinook Energy Inc (Chinook) is an oil and gas company that offers exploration, development and production of oil and gas properties in Western Canada. The company explores and develops crude oil, natural gas liquids and natural gas. It develops inventory from the BBT Concession, exploration …
  • Solco Biomedical Co Ltd (043100):医療機器:M&Aディール及び事業提携情報
    Summary Solco Biomedical Co Ltd (Solco) is a medical device company that manufactures surgical instruments. The company develops and produces implants for orthopedics, neurosurgery, surgical instruments and home functional health products. Its surgical instruments comprise forceps, scissors, needle …
  • Chubu Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Endocyte Inc (ECYT):企業の財務・戦略的SWOT分析
    Summary Endocyte Inc (Endocyte) is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline products include Lu-PSMA-617 and Ac-PSMA-617 for radiologand therapy, and FITC CAR-T. Endocyte's proprietary small molecule dr …
  • Alfresa Holdings Corporation:企業の戦略・SWOT・財務情報
    Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bayer AG (BAYN):医療機器:M&Aディール及び事業提携情報
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products for human and animal health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company's pr …
  • Atrium Health:企業の戦略的SWOT分析
    Atrium Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • CBRE Group, Inc.:企業の戦略・SWOT・財務分析
    CBRE Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary CBRE Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • American Outdoor Brands Corporation:戦略・SWOT・企業財務分析
    American Outdoor Brands Corporation - Strategy, SWOT and Corporate Finance Report Summary American Outdoor Brands Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Tel-Instrument Electronics Corp.:企業の戦略・SWOT・財務情報
    Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report Summary Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • TIS Inc (3626):企業の財務・戦略的SWOT分析
    TIS Inc (3626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Bruce Power LP:企業の戦略的SWOT分析
    Bruce Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Netsmart Technologies Inc:企業の戦略的SWOT分析
    Netsmart Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Nanosonics Ltd (NAN):企業の財務・戦略的SWOT分析
    Nanosonics Ltd (NAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CSB Bancorp Inc (CSBB):企業の財務・戦略的SWOT分析
    CSB Bancorp Inc (CSBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Clinigen Group Plc (CLIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It off …
  • Pt Indofood Sukses Makmur Tbk:企業の戦略・SWOT・財務分析
    Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Norfolk Southern Corp (NSC):企業の財務・戦略的SWOT分析
    Norfolk Southern Corp (NSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆